Today, I tuned into a press conference hosted by the National Institutes of Health with Health and Human Services Secretary Kathleen Sebelius, announcing a new collaborative program to accelerate the current arduous process of bringing drugs from the lab to market. NIH’s new initiative, Discovering New Therapeutic Uses for Existing Molecules, is a huge step forward for drug development, aiming to expedite and increase efficiency of current protocol.
According to NIH Director Francis S. Collins, M.D., Ph.D., it currently takes 2 billion dollars and 14 years to move a drug from lab to clinic, and very few ever make it to approval. In fact, he says, out of the 4,500 identified diseases today, only about 250 have associated treatment therapies.





Greetings from the 
The Full Spectrum Blog is 
